Evidence map›Paper›PMID 40549905›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

SARS-CoV-2 nucleocapsid protein directly prevents cGAS-DNA recognition through competitive binding.

Theresia Gutmann, David Kuster, Anthony A Hyman

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. SARS-CoV-2 nucleocapsid protein directly prevents cGAS-DNA recognition through competitive binding.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Theresia Gutmann *Max Planck Institute of Cell Biology and Genetics, Dresden 01307, Germany.ORCID 0000-0003-0562-2880
David Kuster *Max Planck Institute of Cell Biology and Genetics, Dresden 01307, Germany.ORCID 0000-0002-8157-9223
Anthony A HymanMax Planck Institute of Cell Biology and Genetics, Dresden 01307, Germany.ORCID 0000-0003-0851-704X

Funding

Deutsche Forschungsgemeinschaft (DFG) 471561953NOMIS Stiftung (NOMIS Foundation) noneVolkswagen Foundation (VolkswagenStiftung) 98 195
6 · The paper itself

Abstract

A hallmark of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is the delayed interferon response. Interferons are typically produced upon host recognition of pathogen- or damage-associated molecular patterns, such as nucleic acids. While the mechanisms by which SARS-CoV-2 evades host recognition of its RNA are well studied, how it evades immune responses to cytosolic DNA-leaked from mitochondria or nuclei during infection-remains poorly understood. Here, we demonstrate that the SARS-CoV-2 nucleocapsid protein directly suppresses DNA sensing by cyclic guanosine monophosphate-adenosine monophosphate synthase (cGAS). Although primarily known for packaging the viral RNA genome, we uncover that the SARS-CoV-2 nucleocapsid protein also binds DNA with high affinity and competitively blocks cGAS activation. Using cell-free biochemical and biophysical approaches, including single-molecule optical tweezers, we show that the nucleocapsid protein binds to DNA at nanomolar concentrations and cocondenses with DNA at micromolar concentrations, thereby impeding stable cGAS-DNA interactions required for signal propagation. Hyperphosphorylation of the nucleocapsid protein diminishes its competitive binding capacity. Our findings reveal an unexpected role of the SARS-CoV-2 nucleocapsid protein in directly suppressing the cGAS-STING pathway, strongly suggesting that this contributes to the delayed interferon response during infection. This study raises the possibility that nucleocapsid proteins of other RNA viruses may also exhibit moonlighting functions by antagonizing host nucleic acid-sensing pathways.

Indexed as

Coronavirus Nucleocapsid ProteinsCOVID-19DNANucleotidyltransferasesPhosphoproteinsSARS-CoV-2Binding, CompetitiveCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseHumansProtein BindingcGAS protein, humanCoronavirus Nucleocapsid ProteinsCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseDNAnucleocapsid phosphoprotein, SARS-CoV-2NucleotidyltransferasesPhosphoproteinsbiomolecular condensatescGAScoronavirusinnate immune systemnucleocapsid protein

Identifiers

PMID40549905
PMCPMC12232725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.